Analysis of cellular immune disturbances in COVID-19 for therapeutic stratification and prediction of long-term immunity.
- Funded by Bundesministerium für Bildung und Forschung [German Federal Ministry of Education and Research] (BMBF)
- Total publications:4 publications
Grant number: 01KI20161
Grant search
Key facts
Disease
COVID-19Start & end year
20202021Known Financial Commitments (USD)
$268,958.64Funder
Bundesministerium für Bildung und Forschung [German Federal Ministry of Education and Research] (BMBF)Principal Investigator
Dr. Eva SchrezenmeierResearch Location
GermanyLead Research Institution
Charité-Universitätsmedizin BerlinResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen morphology, shedding & natural history
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
discovery - This research project aims at expanding knowledge on human primary and secondary antigen-specific B lineage responses to a novel pathogen - severe acute respiratory syndrome corona virus-2 (SARS-CoV-2). We will study the characteristics of host-SARS-CoV-2 interaction with B lineage adaptive immunity including induction of anergy among different clinical courses of Corona Virus disease 2019 (COVID-19). The study will provide mechanistic evidence for novel treatment strategies currently adapted from rheumatology by comparing the immune response by COVID-19 infected individuals with those known from rheumatologic patients. We will further investigate long-term protective immunity after SARS-CoV-2 infection by analyzing serological and "steady state" antigen-specific B cells in the blood and bone marrow.
Publicationslinked via Europe PMC
Last Updated:an hour ago
View all publications at Europe PMC